![John Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 730 352 $ in data 31/05/2026
John Doyle is Chief Financial & Accounting Officer at Cognition Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at 4D Pharma Plc from 2022 to 2023, Chief Financial Officer, Treasurer & Senior VP at Chiasma, Inc. in 2021, Vice President-Finance & Investor Relations at Verastem, Inc. from 2019 to 2020, Head-Financial Planning & Analysis at SimpliVity Corp.
from 2016 to 2018, Director-Business Unit Financial Planning at PAREXEL International Corp.
from 2015 to 2016.
Education includes undergraduate studies at the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/05/2026 | 618.942 ( 0,69% ) | 730 352 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/05/2023 |
| Società | Posizione | Fine |
|---|---|---|
| 4D PHARMA PLC | Direttore Finanziario/CFO | 30/03/2023 |
| CHIASMA, INC. | Direttore Finanziario/CFO | 05/08/2021 |
| VERASTEM, INC. | Contatto Relazioni con gli Investitori | 01/12/2020 |
SimpliVity Corp.
 SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Corporate Officer/Principal | 01/02/2018 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/04/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Technology Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
